Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Influenza

Peptide found in frog mucus protects against influenza virus

In the search for new drugs to treat cases of flu, scientists have found a unique class of antiviral agent in amphibians.

Hydrophylax bahuvistara or fungoid frog

Source: Uajith / Wikipedia Commons

Researchers have discovered that a host defence peptide, taken from the skin of the southern Indian Hydrophylax bahuvistara frog, can destroy many strains of human flu.

There is an increasing need for new antiviral agents against influenza-A viruses as during flu pandemics there is insufficient time to produce vaccines. Frog mucus contains a number of molecules known to be capable of killing some bacteria and viruses.

Researchers have discovered that a host defence peptide (HDP), taken from the skin of the southern Indian Hydrophylax bahuvistara frog, can destroy many strains of human flu.

Published in Immunity[1] (18 April 2017), the study found that by targeting the conserved stalk region of H1 haemagglutinin in a similar way to antibodies induced by universal flu vaccines, the HDP, which they named urumin, could physically destroy drug-resistant H1 influenza viruses. It was also found to protect mice from lethal influenza infection.

The researchers concluded that urumin could potentially contribute to first-line antiviral treatments during outbreaks of flu, particularly as HDPs are less prone to resistance than conventional drug therapies.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20202705

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Hydrophylax bahuvistara or fungoid frog

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.